Composition for Treating Cirrhosis and Liver Cancer (SB-1121)
NCT05178303
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
134
Enrollment
INDIV
Sponsor class
Conditions
Cirrhosis of the Liver
Interventions
DRUG:
SB-1121(1)
DRUG:
SB-1121(2)
Sponsor
Nguyen Thi Trieu, MD
Collaborators
[object Object]